InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug safety and efficacy testing in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow for more effective and safe therapies to get to the clinic faster due to our superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to help researchers fuel a new era of drug discovery through comprehensive products and services for: - Liver safety - Liver disease - Islet Biology - Oncology & Immunology
Looking for a particular InSphero employee's phone or email?
InSphero Questions
The InSphero annual revenue was $20.6 million in 2026.
Jürg Gysi is the Chairman Board of Directors of InSphero.
67 people are employed at InSphero.
The NAICS codes for InSphero are [32541, 325, 3254, 54, 32, 541].
The SIC codes for InSphero are [87, 873].
Top InSphero Employees
-
Jürg Gysi
Chairman Board of Directors at InSphero
Zürich, ZH, CH3 -
Paul Edgard Clémençon
Chief Business Officer at InSphero
Zürich, ZH, CH23 -
Olivier Frey
Vice President, Technologies and Platforms at InSphero
Schlieren, ZH, CH11 -
24
-
Anna Borgström
Senior Scientist | Deputy VP Liver Safety at InSphero
Zurich, Switzerland2 -
David Fluri
Head of Operations at InSphero
Riehen, BS, CH21 -
Stina Näslund
Head of Human Resources at InSphero
Zürich, ZH, CH21
Related Companies
